Skip to main content
Clinical Trials/NCT01240707
NCT01240707
Completed
Not Applicable

Pathophysiologic Changes in the Respiratory System After Fire Smoke Inhalation

Oslo University Hospital1 site in 1 country40 target enrollmentNovember 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bronchial Asthma
Sponsor
Oslo University Hospital
Enrollment
40
Locations
1
Primary Endpoint
Positive metacholine test (bronchial hyperreactivity).
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Fire smoke inhalation may contribute to intrabronchial inflammation, airway obstruction and impaired gas exchange. In this study the investigators will examine if the scope of inhalation injury can be assessed soon after hospital admission based on clinical markers, biochemical markers, Peak Expiratory Flow (PEF), spirometry and bronchoscopy. At 6 months a lung function test and metacholine test will be performed to examine whether patients have developed increased bronchial hyperreactivity (asthma) or not after the initial fire smoke exposure.

Detailed Description

Fire smoke inhalation may contribute to intrabronchial inflammation, airway obstruction and impaired gas exchange. The scope of injury in fire smoke victims ranges from cough and minor airway irritation to severe respiratory failure and long term mechanical ventilation in the Intensive Care Unit. Some patients with high HbCO-levels are also treated with hyperbaric oxygen therapy. In this study the investigators will examine if the scope of inhalation injury can be assessed soon after admission based on clinical markers, biochemical markers, Peak Expiratory Flow (PEF), spirometry and bronchoscopy. The clinical effect of fiberoptic bronchoscopy after severe smoke inhalation will also be examined. At 6 months a lung function test and metacholine test will be performed to examine whether they have developed asthma/increased bronchial hyperreactivity or not after the initial fire smoke exposure. Lab staff (flowcytometer and cytokine analysis) are unaware of patient identity and whether the patient is a smoke-exposed patient or a healthy volunteer in the control group of non-exposed persons.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
May 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Espen Rostrup Nakstad

MD

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • fire smoke exposed patient
  • \> 18 years of age
  • admitted to hospital

Exclusion Criteria

  • \< 18 years of ager
  • trauma patient
  • Control group (healthy volunteers/hospital staff):
  • \> 18 years of age
  • non-smoker
  • no exposure to fire smoke

Outcomes

Primary Outcomes

Positive metacholine test (bronchial hyperreactivity).

Time Frame: 6 months

At 6 months a lung function test and metacholine test will be performed to examine whether patients have developed asthma/increased bronchial hyperreactivity after the initial fire smoke exposure.

Study Sites (1)

Loading locations...

Similar Trials